Recent advances in tumor-targeting anticancer drug conjugates.
about
Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery SystemsUtilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliveryAntibody-drug conjugates as novel anti-cancer chemotherapeuticsProtecting the normal in order to better kill the cancerPolysaccharide-based Noncovalent Assembly for Targeted Delivery of Taxol.Drug delivery nanoparticles in skin cancersNanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewAntibody drug conjugates: design and selection of linker, payload and conjugation chemistryFolate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugsToxicology of chemically modified graphene-based materials for medical application.Nanoparticles for Improving Cancer Diagnosis.Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.Recent trends in targeted anticancer prodrug and conjugate design.Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications.Zinc(II) coordination complexes as membrane-active fluorescent probes and antibiotics.Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapy.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicFunctionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.Enhancement of cellular uptake and antitumor efficiencies of micelles with phosphorylcholine.The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapyDoxorubicin-conjugated chimeric polypeptide nanoparticles that respond to mild hyperthermia.Needle-free injection of insulin powder: delivery efficiency and skin irritation assessment.Intracellular Distribution-based Anticancer Drug Targeting: Exploiting a Lysosomal Acidification Defect Associated with Cancer Cells.Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release.Accelerated killing of cancer cells using a multifunctional single-walled carbon nanotube-based system for targeted drug delivery in combination with photothermal therapy.Integrin targeting for tumor optical imagingComparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms.Prodrugs for improving tumor targetability and efficiency.Design, Synthesis and Application of Fluorine-Labeled Taxoids as (19)F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery Systems.Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugatesExtracellular molecules involved in cancer cell invasionCell Internalization Studies of Gadofullerene-(ZME-018) Immunoconjugates into A375m Melanoma Cells.Tumor-targeting drug delivery of new-generation taxoids.Apoptotic efficacy of biogenic silver nanoparticles on human breast cancer MCF-7 cell lines.Targeted tumor therapy by Rubia tinctorum L.: analytical characterization of hydroxyanthraquinones and investigation of their selective cytotoxic, adhesion and migration modulator effects on melanoma cell lines (A2058 and HT168-M1).The shape of things to come: structural and synthetic studies of taxol and related compoundsIn search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivativesPreparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity.Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.
P2860
Q26782485-94F77AAC-F062-4971-A3E9-CB735F1EC782Q26786070-29627A65-1172-4603-A522-40BC2AC1D13EQ26800175-CD73A7C7-B476-4450-9DEC-0F6D17AE3526Q26801291-7F7EF79E-1A5E-4418-8611-5F86EEEF768CQ27301912-5C5BD0E7-BD2B-43A4-90A3-53E9EEF1AC88Q28390405-93449995-6204-493D-8C2C-AEF5CB1F5187Q28394719-B6470EBB-DA8D-4C48-A10A-59F11AE9CECFQ28544658-01DB0369-F28E-46A6-A12E-6624C650C2AAQ28829837-C561888A-EE4D-4A4E-AB6E-C30A490664D0Q30427860-108BF15E-FD16-4288-87D7-D4E37AA48CDDQ30442412-77060070-DD73-4BEE-A6C2-84322EC16E9DQ30486828-ADBA8112-D4B6-48D4-8210-FEB850EF7188Q33573762-9688C7C2-4BFF-431B-9BC2-BF51A06106A3Q33715708-F739C48E-278C-44BB-99B8-219181F3B16BQ33767798-52625DEE-ABCE-406D-9602-8D22324B86F1Q33894592-00ED3380-6DAF-4533-A16D-8D1383D378DBQ33911056-21649562-B7A0-46DD-8C1F-E150FF14DC96Q33925595-490D81AF-18E1-4335-92EE-183FBA9650FEQ33972760-81012F8C-0BF2-4D9D-85C9-B49D69450681Q33976984-1DCC0473-30A3-48D0-989D-41F7E9D5F157Q34197322-8F4B0289-8D6A-4E64-A2F7-5292AB948974Q34360945-2A843D31-09B1-466E-9E36-E9CB3679AAF3Q34517871-981F3E22-E4E0-435F-8462-F971B424D790Q34565264-7193A27C-9F7B-42EE-9139-DE3FB2980771Q34910276-85D412C1-70B6-46FF-B24D-81D4C162773AQ34912662-9BD5B261-36F6-4C36-9D04-615958B88C2EQ35013627-B3AE68A7-EF9A-41D2-86A6-F3288ED5DE13Q35095165-24E6E413-92E1-434D-8BF2-18F8E3F6B9F6Q35110101-825DD7AC-C2FB-4D10-B396-914DB28A6356Q35175462-8284FC78-73DC-4A93-9D91-A6F823AD29CAQ35237503-D9159DFD-1CE4-4747-96BB-E615EACE5248Q35626517-AD470C7F-C31A-48CA-A0EC-2A41521929F7Q35765100-5688C4CC-0BB5-417C-ACEA-66331F25A586Q35841052-E4A38779-7077-4465-93C6-FBB99283A414Q35874369-25D1EADC-3B15-4BD2-B9D5-267D0B9E0F8BQ35996314-3CCB9A94-526C-4CE7-8C78-C0EC5616BD86Q36057981-A82ABCF1-72D8-48BC-A887-DBC2E0C5CA1EQ36195107-5638C533-C547-429C-B39C-3E92E1382D66Q36358309-4499AC9E-EA48-4E02-A3F1-A50B66A0F356Q36367986-3F9B5F99-8732-4D52-A4FD-60E6C8D60909
P2860
Recent advances in tumor-targeting anticancer drug conjugates.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Recent advances in tumor-targeting anticancer drug conjugates.
@ast
Recent advances in tumor-targeting anticancer drug conjugates.
@en
type
label
Recent advances in tumor-targeting anticancer drug conjugates.
@ast
Recent advances in tumor-targeting anticancer drug conjugates.
@en
prefLabel
Recent advances in tumor-targeting anticancer drug conjugates.
@ast
Recent advances in tumor-targeting anticancer drug conjugates.
@en
P2093
P1476
Recent advances in tumor-targeting anticancer drug conjugates
@en
P2093
Larisa V Kuznetsova
Stanislav Jaracz
P304
P356
10.1016/J.BMC.2005.04.084
P407
P50
P577
2005-09-01T00:00:00Z